Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.
Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A Jr, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Shiozaki H, et al. Among authors: mizrak kaya d. Oncology. 2016;91(1):55-60. doi: 10.1159/000445998. Epub 2016 Apr 28. Oncology. 2016. PMID: 27120436 Free PMC article.
Global chemotherapy development for gastric cancer.
Harada K, Mizrak Kaya D, Shimodaira Y, Ajani JA. Harada K, et al. Among authors: mizrak kaya d. Gastric Cancer. 2017 Mar;20(Suppl 1):92-101. doi: 10.1007/s10120-016-0655-8. Epub 2016 Oct 7. Gastric Cancer. 2017. PMID: 27718136 Review.
Advanced gastric adenocarcinoma: optimizing therapy options.
Mizrak Kaya D, Harada K, Shimodaira Y, Amlashi FG, Lin Q, Ajani JA. Mizrak Kaya D, et al. Expert Rev Clin Pharmacol. 2017 Mar;10(3):263-271. doi: 10.1080/17512433.2017.1279969. Epub 2017 Feb 3. Expert Rev Clin Pharmacol. 2017. PMID: 28094573 Review.
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. Mizrak Kaya D, et al. Oncology. 2017;93(4):243-248. doi: 10.1159/000475550. Epub 2017 Jul 6. Oncology. 2017. PMID: 28683449
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D, Dong X, Nogueras-González GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Mizrak Kaya D, et al. Med Oncol. 2017 Aug;34(8):135. doi: 10.1007/s12032-017-0994-2. Epub 2017 Jul 6. Med Oncol. 2017. PMID: 28685276
Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Thomas I, Lin Q, Badgwell BD, Ajani JA. Mizrak Kaya D, et al. J Surg Oncol. 2018 Mar;117(4):678-684. doi: 10.1002/jso.24912. Epub 2017 Dec 4. J Surg Oncol. 2018. PMID: 29205363 Free PMC article.
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial.
Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Harada K, et al. Among authors: mizrak kaya d. Target Oncol. 2018 Feb;13(1):99-106. doi: 10.1007/s11523-017-0540-3. Target Oncol. 2018. PMID: 29218623 Free PMC article. Clinical Trial.
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.
Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Shimodaira Y, et al. Among authors: mizrak kaya d. Br J Cancer. 2018 Feb 6;118(3):331-337. doi: 10.1038/bjc.2017.423. Epub 2017 Dec 12. Br J Cancer. 2018. PMID: 29235564 Free PMC article. Clinical Trial.
Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma.
Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Amlashi FG, et al. Among authors: mizrak kaya d. Oncology. 2018;95(2):81-90. doi: 10.1159/000488489. Epub 2018 May 29. Oncology. 2018. PMID: 29843157 Free PMC article.
Potentially curable gastric adenocarcinoma treated without surgery.
Mizrak Kaya D, Nogueras-Gonzáles GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Matamoros A Jr, Devine CE, Das P, Badgwell BD, Ajani JA. Mizrak Kaya D, et al. Eur J Cancer. 2018 Jul;98:23-29. doi: 10.1016/j.ejca.2018.04.012. Epub 2018 May 30. Eur J Cancer. 2018. PMID: 29859338
24 results